Publikationen in Zusammenarbeit mit Forschern von Klinikum der Universität München (15)

2024

  1. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  2. Sport PRactice and its Effects on aortic size and valve function in bicuspid Aortic valve Disease: a cross-sectional report from the SPREAD study

    British Journal of Sports Medicine

  3. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

2023

  1. Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients – results from the Global EXPAND Post-Market study

    European Journal of Heart Failure, Vol. 25, Núm. 3, pp. 411-421

2022

  1. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid

    Pharmacology and Therapeutics, Vol. 237

2021

  1. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Heart Journal, Vol. 42, Núm. 13, pp. 1254-1269

  2. Transcatheter treatment for tricuspid valve disease

    EuroIntervention, Vol. 17, Núm. 10, pp. 791-808

2019

  1. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

    European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195

2017

  1. Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma

    Expert Opinion on Drug Safety, Vol. 16, Núm. 12, pp. 1413-1426

2015

  1. Catheter ablation for atrial fibrillation: Results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II

    Europace, Vol. 17, Núm. 11, pp. 1727-1732

  2. EHRA research network surveys: 6 years of EP wires activity

    Europace, Vol. 17, Núm. 11, pp. 1733-1738

  3. How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey

    Europace, Vol. 17, Núm. 9, pp. 1449-1453

  4. Management of paediatric arrhythmias in Europe: Authors' reply

    Europace

  5. Management of patients with ventricular tachycardia in Europe: Results of the European Heart Rhythm Association survey

    Europace, Vol. 17, Núm. 8, pp. 1294-1299

2014

  1. Current implantable cardioverter-defibrillator programming in Europe: The results of the European heart rhythm association survey

    Europace, Vol. 16, Núm. 6, pp. 935-938